Browsing

2016

ViruCure Therapeutics Ltd.

ViruCure Therapeutics is a biotech company that is developing an oncolytic-virus-based technology platform, NADAV, for the targeted treatment of a wide range of cancers.

Trophea AB

Trophea AB and its subsidiary Trophea Development AB were founded in 2016. Trophea Development AB develops a topical product for the treatment of skin atrophy caused by long-term…

SwanBio Therapeutics Ltd

SwanBio Therapeutics is a gene therapy company developing leading-edge medicines to deliver dramatic clinical efficacy for the treatment of neurological diseases. We are driven by…

Talee Bio, Inc.

Talee Bio has two gene therapy product candidates to treat cystic fibrosis. The major hurdles of gene therapy for cystic fibrosis are poor efficacy (i.e., transduction efficiency,…

Sojournix, Inc.

Sojournix is a clinical stage biopharmaceutical company focused on developing and commercializing novel therapies for the treatment of women’s health and neuroendocrine disorders.

MicroQuin Ltd.

MicroQuin is a biotechnology company founded by Dr. Scott Robinson of Imperial College London and Yang Zheng of the University of Chicago. Focused on a novel and broadly impactful…

Micar Innovation

Micar Innovation is a drug discovery factory. The company has found a niche where it is able to create a large societal impact by improving the quality of life through new…

Mogrify

Mogrify will develop proprietary tailored cellular conversions that power every future cell therapy